These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6647195)

  • 1. The haemodynamic effects of labetalol under conditions of increased levels of circulating catecholamines.
    Struthers AD; Reid JL
    Postgrad Med J; 1983; 59 Suppl 3():104-5. PubMed ID: 6647195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of labetalol on plasma catecholamines at rest and during increased sympathetic activity.
    Carlsen JE; Trap-Jensen J; Svendsen TL; Nielsen PE; Rasmussen S; Christensen NJ
    Postgrad Med J; 1980; 56 Suppl 2():43-8. PubMed ID: 7433342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and haemodynamic effects of increased circulating adrenaline in man. Effect of labetalol, an alpha and beta blocker.
    Struthers AD; Whitesmith R; Reid JL
    Br Heart J; 1983 Sep; 50(3):277-81. PubMed ID: 6615664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of labetalol and propranolol on responses to adrenaline infusion in healthy volunteers.
    Doshi BS; Kulkarni RD; Dattani KK; Anand MP
    Int J Clin Pharmacol Res; 1984; 4(1):29-33. PubMed ID: 6469431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulatory effects of noradrenaline and adrenaline before and after labetalol.
    Richards DA; Prichard BN; Hernández R
    Br J Clin Pharmacol; 1979 Apr; 7(4):371-8. PubMed ID: 444356
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemodynamic dose-response effects of intravenous labetalol in acute myocardial infarction.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Taylor SH
    Postgrad Med J; 1983; 59 Suppl 3():98-103. PubMed ID: 6647215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
    Martinand A; Lardoux H; Corvol P; Milliez P
    Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I.V. Labetalol during coronary artery surgery.
    Joucken K
    Acta Anaesthesiol Belg; 1983; 34(1):15-26. PubMed ID: 6845955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of labetalol in healthy volunteers.
    Allonen H; Kanto J; Pakkanen A; Wendelin H
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):517-9. PubMed ID: 7174154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers.
    Baum T; Sybertz EJ
    Fed Proc; 1983 Feb; 42(2):176-81. PubMed ID: 6130003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of labetalol and phentolamine on plasma catecholamine concentrations in anesthetized dogs].
    Nakai T; Sakio H; Isobe K; Iwatsuki K; Yamada R; Okuda C
    Masui; 1983 May; 32(5):548-53. PubMed ID: 6620533
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of labetalol in chronic two-kidney Goldblatt hypertension (2-KGH) in rats.
    Gulati OP; Gulati N
    Arch Int Pharmacodyn Ther; 1980 Feb; 243(2):255-60. PubMed ID: 6990887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential haemodynamic effects of labetalol at rest and during exercise in essential hypertension.
    Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
    Postgrad Med J; 1980; 56 Suppl 2():21-6. PubMed ID: 7433338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of labetalol as a moderate hypotensive agent in otological operations--plasma concentrations after intravenous administration.
    Kanto J; Pakkanen A; Allonen H; Kleimola T; Mäntylä R
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):191-4. PubMed ID: 7390669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous labetalol in severe hypertension. Effects on blood pressure, plasma renin activity and catecholamines.
    Lechi A; Picotti GB; Covi G; Pomari S; Pedrolli E; Cesura AM; Danti G; Mattioli M
    Arzneimittelforschung; 1981; 31(3):524-6. PubMed ID: 7013770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of labetalol on plasma renin, aldosterone, and catecholamines in hypertensive patients.
    Lijnen PJ; Amery AK; Fagard RH; Reybrouck TM; Moerman EJ; De Schaepdryver AF
    J Cardiovasc Pharmacol; 1979; 1(6):625-32. PubMed ID: 94628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of chronic theophylline therapy to alter circulating catecholamines.
    Whyte KF; Addis GJ; Whitesmith R; Reid JL
    Eur J Respir Dis; 1987 Apr; 70(4):221-8. PubMed ID: 3582518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
    Hauger-Klevene JH
    Pharmatherapeutica; 1981; 3(1):46-54. PubMed ID: 7033992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate haemodynamic and metabolic effects of intravenous labetalol in the exercising forearm.
    Hartling OJ; Svendsen TL; Trap-Jensen J
    Postgrad Med J; 1980; 56 Suppl 2():17-20. PubMed ID: 7433337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol.
    Baum T; Watkins RW; Sybertz EJ; Vemulapalli S; Pula KK; Eynon E; Nelson S; Vliet GV; Glennon J; Moran RM
    J Pharmacol Exp Ther; 1981 Aug; 218(2):444-52. PubMed ID: 7252843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.